Technical Analysis for ALZN - Alzamend Neuro, Inc.

Grade Last Price % Change Price Change
F 4.35 1.16% 0.05
ALZN closed up 1.16 percent on Wednesday, August 4, 2021, on 36 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical ALZN trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 1.16%
Narrow Range Bar Range Contraction 1.16%
NR7 Range Contraction 1.16%
NR7-2 Range Contraction 1.16%
New 52 Week Low Weakness 1.16%
Wide Bands Range Expansion 1.16%
Older End-of-Day Signals for ALZN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 % about 16 hours ago
Down 1% about 17 hours ago
Fell Below Previous Day's Low about 17 hours ago
New 52 Week Low about 17 hours ago
60 Minute Opening Range Breakdown about 18 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Alzamend Neuro, Inc., a preclinical stage biopharmaceutical company, focuses on developing products for the treatment of neurodegenerative diseases and psychiatric disorders. The company's lead product candidate is AL001 for the treatment of Alzheimer's and other neurodegenerative diseases and psychiatric disorders. It is also developing AL002, a cell-based therapeutic vaccine, which seeks to restore the ability of the patient's immunological system to Alzheimer's. The company was incorporated in 2016 and is headquartered in Tampa, Florida.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Biology Medication Neuroscience Alzheimer's Disease Psychiatric Diagnosis Dementia Neurodegenerative Diseases Neurodegeneration Amyloidosis Alzheimer's Psychiatric Disorders Preclinical Stage Biopharmaceutical Treatment Of Alzheimer's Treatment Of Neurodegenerative Diseases

Is ALZN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 33.55
52 Week Low 4.21
Average Volume 3,085,974
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 5.43
10-Day Moving Average 4.82
Average True Range 1.37
ADX 14.31
+DI 21.02
-DI 16.98
Chandelier Exit (Long, 3 ATRs) 4.18
Chandelier Exit (Short, 3 ATRs) 8.31
Upper Bollinger Bands 7.02
Lower Bollinger Band 3.83
Percent B (%b) 0.16
BandWidth 58.80
MACD Line -1.17
MACD Signal Line -1.22
MACD Histogram 0.0529
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.85
Resistance 3 (R3) 4.85 4.70 4.76
Resistance 2 (R2) 4.70 4.57 4.69 4.73
Resistance 1 (R1) 4.52 4.49 4.45 4.52 4.71
Pivot Point 4.37 4.37 4.33 4.36 4.37
Support 1 (S1) 4.19 4.24 4.12 4.19 3.99
Support 2 (S2) 4.04 4.16 4.03 3.97
Support 3 (S3) 3.86 4.04 3.94
Support 4 (S4) 3.86